INTUITIVE SURGICAL INC
ISRG
54 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 3 9:29 PM | FREDRIK WIDMAN | Proposed Sale | 118 | $487.18 | $57.5K | — | View → |
| Mar 3, 2026 | Mar 3 9:17 PM | MYRIAM CURET MCADAMS | Proposed Sale | 4,728 | $487.18 | $2.3M | — | View → |
| Mar 2, 2026 | Mar 2 9:09 PM | MYRIAM CURET MCADAMS | Proposed Sale | 125 | $492.59 | $61.6K | — | View → |
| Feb 27, 2026 | Mar 2 8:41 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 2,345 | $499.71 | $1.2M | 409(I) | View → |
| Feb 27, 2026 | Feb 27 11:43 PM | WADORS PATRICIA LSVP Chief Human Resources Offi | Sale | 220 | $499.71 | $109.9K | 0(D) | View → |
| Feb 27, 2026 | Feb 27 9:24 PM | FREDRIK WIDMAN | Proposed Sale | 249 | $499.71 | $124.4K | — | View → |
| Feb 27, 2026 | Feb 27 9:11 PM | MYRIAM CURET MCADAMS | Proposed Sale | 2,345 | $499.71 | $1.2M | — | View → |
| Feb 27, 2026 | Feb 27 9:09 PM | PATRICIA WADORS | Proposed Sale | 220 | $499.71 | $109.9K | — | View → |
| Feb 18, 2026 | Feb 18 9:37 PM | BRIAN MILLER | Proposed Sale | 647 | $493.35 | $319.2K | — | View → |
| Feb 11, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 421 | $494.96 | $208.4K | 409(I) | View → |
| Feb 10, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $494.65 | $51.9K | 830(I) | View → |
| Feb 11, 2026 | Feb 11 10:17 PM | Fredrik WidmanVP Corporate Controller | Sale | 133 | $494.96 | $65.8K | 660(D) | View → |
| Feb 11, 2026 | Feb 11 9:05 PM | FREDRIK WIDMAN | Proposed Sale | 133 | $494.96 | $65.8K | — | View → |
| Feb 11, 2026 | Feb 11 9:02 PM | MYRIAM CURET MCADAMS | Proposed Sale | 421 | $494.96 | $208.4K | — | View → |
| Feb 10, 2026 | Feb 10 9:04 PM | MYRIAM CURET MCADAMS | Proposed Sale | 105 | $494.65 | $51.9K | — | View → |
| Jan 29, 2026 | Jan 31 2:16 AM | Curet MyriamEVP & Chief Medical Officer | Sale | 126 | $520.02 | $65.5K | 0(D) | View → |
| Jan 29, 2026 | Jan 29 9:01 PM | MYRIAM CURET MCADAMS | Proposed Sale | 126 | $520.02 | $65.5K | — | View → |
| Jan 27, 2026 | Jan 28 9:34 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 230 | $532.61 | $122.5K | 0(D) | View → |
| Jan 27, 2026 | Jan 28 9:20 PM | Gary S GuthartDirector | Sale | 27,300 | $530.24 | $14.5M | 15,720(I) | View → |
| Jan 27, 2026 | Jan 27 10:18 PM | GARY S GUTHART | Proposed Sale | 24,500 | $530.10 | $13.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 4,654 | $0.00 | 0(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 989 | $0.00 | 1,133(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Grant/Award | 1,627 | $0.00 | 1,627(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Grant/Award | 21,247 | $0.00 | 13,441(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 6,105 | $0.00 | 6,866(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Grant/Award | 8,778 | $0.00 | 26,334(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Option Exercise | 8,393 | $0.00 | 10,299(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option Exercise | 2,595 | $0.00 | 2,918(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Grant/Award | 7,721 | $0.00 | 4,928(D) | View → |
| Feb 10, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 943 | $229.39 | 838(D) | View → |
| Feb 10, 2026 | Feb 11 10:17 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 567 | $0.00 | 567(D) | View → |
| Feb 10, 2026 | Feb 10 9:28 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 1,436 | $0.00 | 1,436(D) | View → |
| Feb 10, 2026 | Feb 10 9:18 PM | Gary S GuthartDirector | Option Exercise | 2,633 | $0.00 | 2,633(D) | View → |
| Feb 10, 2026 | Feb 10 8:51 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 315 | $0.00 | 314(D) | View → |
| Feb 10, 2026 | Feb 10 8:26 PM | Iman JeddiSVP & GM da Vinci Platforms & | Option Exercise | 838 | $0.00 | 838(D) | View → |
| Feb 10, 2026 | Feb 10 8:16 PM | Jamie SamathEVP & CFO & Enterprise Technol | Option Exercise | 1,077 | $0.00 | 1,077(D) | View → |
| Feb 10, 2026 | Feb 10 7:16 PM | Henry L CharltonEVP & Chief Commercial and Mkt | Option Exercise | 1,077 | $0.00 | 1,077(D) | View → |
| Feb 10, 2026 | Feb 10 6:54 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option Exercise | 838 | $0.00 | 838(D) | View → |
| Jan 28, 2026 | Jan 31 2:28 AM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Grant/Award | 8,287 | $0.00 | 5,585(D) | View → |
| Jan 28, 2026 | Jan 31 2:24 AM | Gary LoebEVP & Chief Legal and Complian | Grant/Award | 4,641 | $0.00 | 2,098(D) | View → |